Phardis offers clients secondary packaging of medicines in their structures directly, thanks to its AIFA authorised, pharmaceutical workshop. Activities are carried out in compliance with GMP procedures and satisfy regulatory requirements set by laws in force. The extension obtained after initial authorisation now enables the company to manage medicines to be used for clinical trial purposes.
Alongside changing leaflet, changing case, attaching stickers of various kinds, the company can now offer a highly specialised secondary packaging service; not just for products to be sold, but also for medicines addressed to clinical trial centres.